buthionine sulfoximine has been researched along with antimony sodium gluconate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carter, KC; Mullen, AB; Pereira, OC; Spickett, C; Sundar, S | 1 |
Boitelle, A; Carter, KC; Hutchison, S; Mullen, AB; Murray, HW; Sundar, S | 1 |
2 other study(ies) available for buthionine sulfoximine and antimony sodium gluconate
Article | Year |
---|---|
The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Buthionine Sulfoximine; Drug Resistance; Female; Glutathione; Leishmania donovani; Leishmaniasis, Visceral; Male; Mice; Mice, Inbred BALB C; Paromomycin; Phosphorylcholine | 2003 |
Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy.
Topics: Animals; Antimony Potassium Tartrate; Antimony Sodium Gluconate; Antiprotozoal Agents; Buthionine Sulfoximine; Cricetinae; Drug Resistance; Female; Humans; Hydrogen Peroxide; Interleukin-6; Leishmania donovani; Lipopolysaccharides; Macrophages; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Nitrites; Spleen; Virulence | 2005 |